Skip to content
Dx

HCPCS Level II · Medical services and quality measures

M1003Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About M1003

M1003 is an HCPCS Level II code in the M series (medical services and quality measures), describing tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy.

It was added to HCPCS effective 01/01/2019, and its current record took effect 01/01/2023.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Tb scr 12 mo pri fst bio dz
Date added
01/01/2019
Action effective
01/01/2023
BETOS
Z2

Related M10xx codes

Common questions about M1003

Is HCPCS M1003 still valid?

Yes. M1003 is active in the CMS October 2026 HCPCS file.

Does Medicare cover M1003?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.